Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Peginterferon Beta-1A

Drug Discount Contracts with Option to Join - 0029-Rvbeitr.62-2023

Open House Drug Discount Agreements Ferric Derisomaltose, Atc B03ac08

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Latanoprost (Edp)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Substance Raltegravir

Open House Drug Rebate Contracts Formoterol, Glycopyrronium Bromide and Budesonide, Atc R03al11

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Piribedil

Drug Discount Contracts According to § 130A Paragraph 8 Sgb V in the Context of Open House Procedures

Open House Discount Contracts 2023-07

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.